Entrada Therapeutics, Inc. (TRDA)
NASDAQ: TRDA · Real-Time Price · USD
6.91
-0.11 (-1.57%)
Jun 27, 2025, 4:00 PM - Market closed
Entrada Therapeutics Market Cap
Entrada Therapeutics has a market cap or net worth of $243.62 million as of June 27, 2025. Its market cap has decreased by -51.13% in one year.
Market Cap
243.62M
Enterprise Value
-81.89M
1-Year Change
-51.13%
Ranking
Category
Stock Price
$6.91
Market Cap Chart
Since the IPO on October 29, 2021, Entrada Therapeutics's market cap has decreased from $251.01M to $243.62M, a decrease of -2.94%. That is a compound annual growth rate of -0.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2025 | 247.85M | -59.51% |
| Dec 31, 2024 | 612.16M | 21.70% |
| Dec 29, 2023 | 503.01M | 18.72% |
| Dec 30, 2022 | 423.70M | -20.71% |
| Dec 31, 2021 | 534.36M | 112.88% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.28B |
| Johnson & Johnson | 366.40B |
| AbbVie | 327.47B |
| Novo Nordisk | 301.06B |
| UnitedHealth Group | 273.97B |
| Abbott Laboratories | 239.05B |
| Novartis AG | 231.01B |
| AstraZeneca | 216.45B |